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Abstract: INTRODUCTION AND BACKGROUND As cancer is developing into a chronic disease due
to longer survival, continuity and coordination of oncological care are becoming more important for pa-
tients. As radiation oncology departments are an integral part of cancer care and as repeat irradiation
becomes more commonplace, the relevance of continuity and coordination of care in operating procedures
is increasing. This study aims to perform a single-institution analysis of cancer patients in which con-
tinuity and coordination of care matters most, namely the highly selected group with multiple repeat
course radiotherapy throughout their chronic disease. MATERIALS AND METHODS All patients who
received at least five courses of radiotherapy at the Department of Radiation Oncology at the Univer-
sity Hospital Zurich from 2011 to 2019 and who were alive at the time of the initiation of this project
were included into this study. Patient and treatment characteristics were extracted from the hospital
information and treatment planning systems. All patients completed two questionnaires on continuity of
care, one of which was designed in-house and one of which was taken from the literature. RESULTS Of
the 33 patients identified at baseline, 20 (60.6%) participated in this study. A median of 6 years (range
3-13) elapsed between the first and the last visit at the cancer center. The median number of involved
primary oncologists at the radiation oncology department was two (range 1-5). Fifty-seven percent of
radiation therapy courses were preceded by a tumor board discussion. Both questionnaires showed high
levels of experienced continuity of care. No statistically significant differences in experienced continu-
ity of care between groups with more or less than two primary oncologists was found. DISCUSSION
AND CONCLUSION Patients treated with multiple repeat radiation therapy at our department over
the past decade experienced high levels of continuity of care, yet further efforts should be undertaken to
coordinate care among oncological disciplines in large cancer centers through better and increased use of
interdisciplinary tumor boards.
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Abstract 
Introduction and background: As cancer is developing into a chronic disease due to longer survival, continuity 
and coordination of oncological care are becoming more important for patients. As radiation oncology departments 
are an integral part of cancer care and as repeat irradiation becomes more commonplace, the relevance of continuity 
and coordination of care in operating procedures is increasing. This study aims to perform a single-institution analysis 
of cancer patients in which continuity and coordination of care matters most, namely the highly selected group with 
multiple repeat course radiotherapy throughout their chronic disease.
Materials and methods: All patients who received at least five courses of radiotherapy at the Department of Radia-
tion Oncology at the University Hospital Zurich from 2011 to 2019 and who were alive at the time of the initiation 
of this project were included into this study. Patient and treatment characteristics were extracted from the hospital 
information and treatment planning systems. All patients completed two questionnaires on continuity of care, one of 
which was designed in-house and one of which was taken from the literature.
Results: Of the 33 patients identified at baseline, 20 (60.6%) participated in this study. A median of 6 years (range 
3–13) elapsed between the first and the last visit at the cancer center. The median number of involved primary 
oncologists at the radiation oncology department was two (range 1–5). Fifty-seven percent of radiation therapy 
courses were preceded by a tumor board discussion. Both questionnaires showed high levels of experienced continu-
ity of care. No statistically significant differences in experienced continuity of care between groups with more or less 
than two primary oncologists was found.
Discussion and conclusion: Patients treated with multiple repeat radiation therapy at our department over the 
past decade experienced high levels of continuity of care, yet further efforts should be undertaken to coordinate care 
among oncological disciplines in large cancer centers through better and increased use of interdisciplinary tumor 
boards.
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Introduction and background
As cancer is developing into a chronic disease, conti-
nuity and coordination of oncological care are becom-
ing more important. Continuity and coordination of 
care are broad and often only loosely defined concepts 
which intend to capture the integration of patient care 
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over time [1]. Continuity of care is often taken to refer 
to the patient/”subjective” view, whereas the coordina-
tion of care is supposed to reflect the provider/”objective” 
view [2]. The subjective component is best measured as 
a patient reported experience measure (PREM) [3]. The 
objective component can be evaluated with the help of 
different care metrics. Continuity of care has been sep-
arated into three parts in the literature: informational, 
managerial and relational aspects [4]. Informational con-
tinuity refers to the inclusion of a patient’s past medical 
history and all relevant individual circumstances when 
making decisions about a patient’s current care need 
[4]. Managerial continuity means a holistic and well-
organized diagnostic and therapeutic scheme in which 
a patient is managed over time [4]. And relational con-
tinuity is used to describe the building of a lasting rela-
tionship between a patient and the involved healthcare 
providers [4]. Coordination of care has been separated 
into two subcategories, management coordination—good 
collaboration between care providers—and information 
coordination—the unseeming and coordinated flow and 
use of information regarding patient cases [5].
The beneficial effect of the continuity and coordina-
tion of care has been demonstrated for various specific 
patient populations [6, 7]. There is evidence that case 
mortality is lower when cancer patients receive treat-
ment at comprehensive cancer centers where treating 
physicians are familiar with the patient history [8]. Better 
continuity of care is positively associated with improved 
symptom palliation and supportive care [9]. Continuity 
and coordination of care have also been shown to lead 
to an improved patient experience, as it enables health-
care providers to focus more on the patient rather than 
on the disease [10]. Continuity and coordination of care 
was shown to be a major contributor to patient satisfac-
tion [11]. In addition, there is an indication that continu-
ity of care in cancer patients improves when less rather 
than more health care professionals as well as integrated 
palliative care teams are involved [12]. Continuity and 
coordination of care have also been of increasing interest 
to healthcare policy makers, as they look at streamlining 
care pathways of patients, which include various clinical 
specialties at large comprehensive cancer centers where 
high staff turn-over not uncommon [13].
Clinical cancer care pathways are known to be amongst 
the most difficult to manage [14]. As cancer histologies 
are being broken down into more and more sub-groups, 
cancer patients are being confronted with a growing 
numbers of medical subspecialists and subspeciality 
care providers [5]. Of all patients diagnosed with cancer, 
every second will receive radiotherapy (RT) during their 
course of disease [15]. Hence radiation oncology depart-
ments constitute an integral part of all comprehensive 
cancer centers globally. The overwhelming majority of 
patients presenting for treatment at a radiation oncology 
department, however, will only receive RT once during 
their disease course or even lifetime [16]. Yet as cancer 
is becoming a chronic condition, and as more and more 
patients outlive their diagnosis by many years, the prob-
ability of frequenting radiation oncology departments 
multiple times and receiving multiple radio-oncological 
treatments increases in parallel.
The aim of this study is to explore aspects of continuity 
and coordination of care in the highly selected and small 
group of patients who were treated with multiple courses 
RT at the Department of Radiation Oncology at the Uni-
versity Hospital Zurich (USZ) for their cancer diagnosis 
during an extended period of time of their chronic cancer 
disease. As radiation oncology department at a leading 
university hospital in Switzerland, our department func-
tions as an integral part of the Comprehensive Cancer 
Center Zurich (CCCZ). Though this is a single-center 
analysis, we hope it will inspire other radiation oncology 
departments to conduct similar studies, so that pooled-
data or multi-center studies will be possible in the future 




All patients included in this study received at least five 
courses of RT at the Department of Radiation Oncology 
of the USZ within the last decade. This large number of 
RT courses was chosen to investigate the most complex 
cohort of patients with the most treatments and year-
long follow-up, where continuity and coordination of 
care appear most important. A cut-off of two or three RT 
treatments seemed too low to adequately assess conti-
nuity and coordination of care over time, which is why 
a minimum of five RT courses was chosen. A RT course 
was defined as a prescribed RT regimen to one anatomi-
cal site for one medical indication. To identify this patient 
cohort, we screened all treatment records in the Record 
and Verify System (Aria® Version 15, Varian®) to long-list 
patients who received at least five RT courses between 
2011 and 2019. We used the term multiple repeat RT 
(MRRT) to characterize the treatment of such patients. 
A short-list of patients was then obtained by selecting 
patients who were still alive at the time of study design 
and initiation in fall 2020.
Electronic patient records
Treatment variables were extracted from the treatment 
planning system ARIA® and demographic and disease 
variables from the hospital information system (HIS) 
KISIM™. Treatment parameters included treatment site, 
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RT course identifier, plan name, RT start date, RT end 
date, RT fractionation schedule, single dose, total dose 
and course count. Demographic and disease parame-
ters comprised unique patient identifier, gender, date of 
birth, survival status, primary diagnosis, name of primary 
oncologists (PO) per prescribed RT course, list of clini-
cally involved departments at USZ in the patient-specific 
cancer care pathway, clinical department with follow-up 
lead and involvement of a multidisciplinary tumor board 
(MDT) in RT recommendation per RT course. PO was 
defined as the radiation oncologist who consulted the 
patient, prescribed treatment, contoured and signed off 
on the delineation of the target volumes and organs at 
risks, approved the treatment plans and regularly moni-
tored the RT. Clinically involved department was defined 
as regularly patient-facing, resulting in pathology, radiol-
ogy and nuclear medicine departments being excluded 
from the head count of involved disciplines, even though 
they hold a key role for every cancer case under dis-
cussion and treatment at CCCZ. Clinical department 
with follow-up lead was defined as the department who 
remained in most regular contact with the patient, deter-
mined clinical and imaging follow-up schedules, initi-
ated MDT discussions, communicated new findings to 
the patient and directed next therapeutic steps. MDT 
involvement was defined as a patient case having been 
presented and discussed prior to a new RT course.
Employed measures for continuity and coordination 
of care
The objective component of continuity and coordination 
of care was defined as (1) the number of different POs at 
our department which managed radio-oncological care 
over time; (2) the number of RT courses preceded by an 
MDT as surrogate of the coordination of care amongst 
various involved clinical departments. The proxy vari-
ables for measuring the objective components of conti-
nuity and coordination of care were manually extracted 
from the HIS as described above.
To capture the subjective patient-reported component, 
we used two questionnaires, (1) one in-house developed 
questionnaire, consisting of ten questions and developed 
to address psycho-oncological, palliative and relational 
aspects (Additional file 1: Questionnaire 1), and (2) one 
validated questionnaire with 17 questions from the lit-
erature [17] (Additional file 1: Questionnaire 2). The in-
house developed questionnaire was created to capture 
psycho-oncological, palliative and the relational aspect 
of the continuity of care within our department. It was 
developed by a team consisting of radiation oncologists, 
an experienced psycho-oncologist as well as a senior pal-
liative care specialist. Patients were asked to answer eight 
questions on a four-point Likert scale: 1 = does not apply, 
2 = does rather not apply, 3 = does rather apply, and 
4 = does apply, with the 8th question designed as “yes” vs. 
“no” question and with the 10th question being an open 
one with the option to provide individual comments in a 
text box. The highest score on all scorable questions was 
32, the lowest score was 4. The questionnaire was created 
in German and, for the purposes of presentation in this 
paper, translated to English (Additional file 1: Question-
naire 1). The second questionnaire, called “Statements on 
experienced continuity of care”, is a validated psychomet-
ric testing instrument, originally designed in the United 
Kingdom as an intervention tool, and has also been 
employed in other studies [18, 19]. The questionnaire 
is conceptualized in a way so as to pertain to all three 
components of perceived continuity of care. Patients 
rated all 17 statements on a five-point Likert scale with 
1 = strongly disagree, 2 = disagree, 3 = neutral, 4 = agree 
and 5 = strongly agree. Hence 17 points is the minimum 
attainable score, 85 is the maximum attainable score [18, 
19]. Like in other studies, high experienced continuity 
and coordination of care was said to exist when individ-
ual questionnaire scores exceeded or equaled 75 points 
[17]. For the purposes of this study, the authors of this 
questionnaire, Prof. King and Prof. Nazareth, gave their 
written permission to employ and to translate the ques-
tionnaire to German. The questionnaire was forward-
translated by two independent radiation oncologists, 
and subsequently independently backward-translated to 
guarantee a high level of translation accuracy, as is rec-
ommended in guidelines [20]. The original version of 
Questionnaire 2 can be found in the Appendix as Addi-
tional file 1: Questionnaire 2.
Patients were either contacted via telephone to inquire 
about their willingness to participate in this study, then 
either invited for a brief clinical visit in our department, 
or the study documents incl. the questionnaires were sent 
via mail, or they were introduced to the study at the time 
of a routine clinical follow-up visit during the 3-month 
period March to May 2020. Upon having given written 
consent, patients completed the two questionnaires inde-
pendently and at their own discretion. Study materials 
and filled-out questionnaires were subsequently returned 
via postal service or directly handed to the study office 
team. Patients not reached by phone were contacted via 
mail. No third attempt to approach was conducted to 
reach unresponsive patients. This project and its design 
were approved by the Swiss Cantonal Ethics Committee 
before study initiation (BASEC# 2021-00104).
Data analysis
All clinical and treatment data were recorded in the 
spreadsheet program Microsoft® Excel® (Version 16.0). 
Descriptive statistics were calculated for all variables 
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under study. Statistical differences between different 
groups of patients were assessed using the Fisher’s exact 
test due to the small sample size. Statistical significance 
was set at < 0.05. All statistical analyses were conducted 
using the Statistical Software Package STATA® (Version 
16.1). Microsoft® Powerpoint® (Version 16.0) was used 
to compile graphics.
Results
Between 2011 and 2019, 112 patients received at least 
five courses of RT at the Department of Radiation Oncol-
ogy at USZ, totaling at 660 RT courses. At the time of ini-
tiation of this study in the fall 2020, 33 of these patients 
were still alive and were therefore included into this 
study at baseline. Five (15.2%) patients had died by the 
time they were contacted. Of the remaining 28 (84.8%) 
patients, all but one had an up-to-date address and con-
tact details available and were approached; one patient 
had moved abroad without having provided a new postal 
address or telephone number and also did not respond to 
e-mail. Of all contacted patients, 24 (72.7%) initially indi-
cated a willingness to participate in the study. During the 
second encounter, four (12.1%) patients refused to partic-
ipate. Reasons for declining to participate were not want-
ing to be reminded of past therapies, wanting to live in 
the present, or having recently experienced health dete-
rioration and therefore preferring to maximize time with 
family and friends rather than participating in a clinical 
research study. Hence, of the 24 (72.7%) patients who 
initially indicated a willingness to participate, 20 (60.6%) 
took part in this study (see Fig. 1 for a CONSORT dia-
gram). As a result, objective metrics were calculated for 
all 33 (100%) patients, while PREMs were available for 20 
(60.6%) patients.
Patient and treatment characteristics
All 33 patients included in this study had at least one 
histologically verified cancer diagnosis. Twenty patients 
were male (60.6%), median age at diagnosis was 55 (range 
32–75) years. The most common primary histology was 
lung cancer (n = 14, 42.4%). At time of data analysis, 
28 (84.8%) patients were still alive. The median East-
ern Cooperative Oncology Group Performance Status 
(ECOG-PS) before the last RT course was 1 (range 0–2). 
Patient characteristics are summarized in Table 1.
The 33 patients received 210 RT courses, with a median 
of six (range 5–9) RT courses per patient. Forty-six 
(21.9%) prescribed RT courses had a curative, 164 (78.1%) 
a palliative intent. The most common irradiated tumor 
sites were brain metastases (n = 78, 37.1%) and bone 
metastases (n = 59, 28.1%). The median single dose was 
five (range 2–20) Gy, the median number of fractions was 
six (range 1–35), and the median total dose was 30 (range 
6–70) Gy. A median of four (range 1–12) years elapsed 
between the first and last RT course. For an overview of 
compiled treatment parameters, see Table 2.




Alive at start of study in fall 2020?
28 5
Alive when first contacted spring 2021?
NY
24 4
Up-to-date contact information available?
20 4
Willing to participate and returned study documents?
NY
NY
Fig. 1 Consort diagram. Abbreviations: MRRT = Multiple repeat radiotherapy; Y = “Yes”; N = “No”
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Subjective measures for continuity and coordination 
of care
The median score for experienced, mostly relational, 
continuity of care obtained from the first questionnaire 
was 30 (range 25–32), which can be taken to be quite 
high given the highest score attainable when adding all 
scorable questions is 32. The question with the highest 
point score was asking about (1) the overall treatment 
experience at our radiation oncology department and 
the question with the lowest point score was question 
(7) on number of primary POs encountered during one’s 
treatment history. The proportion of patients having 
expressed agreement (3 or 4 points on the Likert scale) to 
questions one through seven and nine was n = 20 (100%). 
A large proportion of patients stated that they would 
opt for an additional course of MRRT if it was medically 
indicated (n = 18; 90%). A rather small proportion of 
patients (n = 8; 40%) reported to have made use of aux-
iliary supportive services available at CCCZ and only 4 
(20%) patients made use of the comments box to provide 
further details on their care experience in the form of 
question (10). No significant differences were detected in 
subjective continuity of care when comparing the group 
of patients who had less or more than two POs over the 
years (p = 0.546). For a summary of PREMs from ques-
tionnaire 1, see Table 3a.
The median score for experienced continuity of care 
obtained from the second questionnaire was 75 (range 
56–84). There were eleven patients (55%) with a total 
score of ≥ 75 points. The question with the highest point 
score (95) was statement (7) on the support of close rela-
tives, and the question with the lowest point score (63) 
was statement (9) regarding worries about relatives. 
There was only one patient (n = 1; 5%) having expressed 
agreement (4 or 5 points on the Likert scale) to all ques-
tions. No significant differences were detected in sub-
jective continuity of care when comparing the group of 
patients who had less or more than two POs over the 
years (p = 0.456). There was also no statistically signifi-
cant difference in achieving a ≥ 75 points score between 
the group of patients who had less or more than two POs 
over the years (p = 0.362). For a summary of PREMs from 
questionnaire 2, see Table  3b. Responses to the second 
questionnaire are also visually displayed in Fig. 2.
Objective measures for continuity and coordination of care
A median of 6 years (range 3–13) elapsed between 
the first and the last follow-up visit at one of the clini-
cal departments of the CCCZ. A total of 119 (56.7%) 
RT courses were preceded by an MDT discussion at 
the CCCZ. The median number of clinical departments 
involved in any given oncological patient care pathway 
was three (range 2–6). The oncology department had 
the follow-up lead for 13 (39.4%) patients and the radia-
tion oncology department for twelve (36.4%) patients. 
For eight (24.2%) patients, other departments had the 
follow-up lead. The median number of involved POs at 
the radiation oncology department for the entire cohort 
of 33 patients was two (range 1–5). A summary of follow-
up data is provided in Table 4.
When putting into perspective the examined objec-
tive measures for continuity of care with the subjective 
Table 1 Patient characteristics
ECOG-PS = Eastern Cooperative Oncology Group Performance Status; 
SCLC = Small cell lung cancer; NSCLC = None small cell lung cancer
a Includes malignant melanoma, head & neck, endocrine, primary brain entities 
as well as cancer of unknown origin
b Between time of official study initiation and time of data collection/analysis, 5 
patients had died before being included in this study
Parameter Data (n = 33 patients)
Age at diagnosis in years, median (range) 55 (32–75)
Female gender, n (%) 13 (39.4%)
Primary tumor histology, n (%)
Lung cancer (SCLC and NSCLC) 14 (42.4%)
Breast cancer 3 (9.1%)
Colorectal cancer 3 (9.1%)
Sarcoma 3 (9.1%)
Urinary tract cancer 3 (9.1%)
Othera 7 (21.2%)
Alive at time of data analysis, n (%)b 28 (84.8%)
ECOG-PS before last RT, median (range) 1 (0–2)
Table 2 Treatment characteristics
RT = Radiation therapy
a Includes soft tissue and mediastinal metastasis
Parameter Data (n = 210 courses)
Number of RT courses per patient, median 
(range)
6 (5–9)
Treatment intent, n (%)
 Curative 46 (21.9%)
 Palliative 164 (78.1%)
Treatment site, n (%)
 Brain 78 (37.1%)
 Bone 59 (28.1%)
 Lung 37 (17.6%)
 Primary 11 (5.2%)
  Othera 26 (11.9%)
Single dose in Gy, median (range) 5 (2–20)
Fractions, median (range) 6 (1–35)
Total dose in Gy, median (range) 30 (6–70)
Time in years between first and last RT course, 
median (range)
4 (1–12)
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results from the validated questionnaire, there was 
no statistically significant difference between sub-
groups. Of the patients scoring ≥ 75 points in the vali-
dated questionnaire, four (36%) were followed-up less 
than 6 years, while seven (64%) were followed-up for 
more than 6 years (p = 0.478). For six patients (55%) 
who scored more ≥ 75 points less than three clini-
cal departments were involved in the process of care, 
while for five (45%) patients more than three played a 
role (p = 0.512). Of the patients scoring ≥ 75 points, the 
majority (n = 3, 73%) was followed-up by the radiation 
oncology department, while three (27%) were followed-
up by other departments, yet also this difference was 
not statistically significant (p = 0.362). In four patients 
(36%) scoring ≥ 75 points, an MDT was never involved 
over the years, while in seven patients (64%) the MDT 
was involved at least once (p = 0.478). For a compila-
tion of the different continuity of care measures, con-
sult Table 5.
Table 3 (a) Summary of selected PREMs from questionnaire 1. (b) Summary of selected PREMs from questionnaire 2
Abbreviations: PREMs = Patient reported experience measures; Pts = Patients; PO = Primary oncologist
Parameter Total (n = 20)  < 2 POs (n = 8)  ≥ 2 Pos (n = 12) p-value (Fisher)
(a)
Median score; points (range) 30 (26–33) 31 (28–33) 30 (26–32) 0.546
Pts with self-reported supportive service needs; n (%) 8 (40%) 3 (63%) 5 (37%) N/A
Pts having made use of text box comments; n (%) 5 (20%) 2 (40%) 3 (60%) N/A
(b)
Median score; points (range) 75 (56–84) 74 (67–79) 75 (64–84) 0.456
Patients scoring ≥ 75; n (%) 11 (55) 3 (38) 8 (67) 0.362


















>= 2 POs < 2 POs
Fig. 2 Proportion of patients with a positive response to Questionnaire 2. A positive score was taken to be a “4” or “5” on the Likert scale. Scoring for 
questions 4, 6, 9, 10, 11, 13 was reversed
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Discussion
Continuity and coordination of care at radiation oncol-
ogy departments have not been studied systematically 
and in detail. Reasons may be that most patients receive 
RT only once in their life. While it always occurred that 
some patients received classical re-irradiation, i.e., RT 
to the same or an adjacent anatomical site and others 
repeat irradiation, i.e., RT to a different anatomical site, 
the population of MRRT patients only started growing 
recently. As MRRT patients are those characterized by 
having undergone the most complex therapy regimes, 
having been followed-up and having outlived their can-
cer diagnosis for several years, this fairly small, as highly 
selected, but growing group of cancer patients are those 
where continuity and coordination of care in radiation 
oncology are most relevant and therefore merit most 
attention.
Yet the importance of continuity and coordination 
of care has been acknowledged and studied in different 
oncological populations: Plate et  al. [17] examined con-
tinuity of care in 231 breast cancer patients treated at 
two Swedish hospitals employing a validated question-
naire. The authors found that continuity of care was 
higher in the larger healthcare facility examined [17]. 
Husain et al. [9] assessed the continuity of care and sup-
portive care needs in 116 advanced lung cancer patients 
in Canada with validated test instruments and concluded 
that patients with less unmet supportive care needs expe-
rienced higher continuity of care [9]. According to King 
et al. [18, 19] questionnaires and psychometric test inter-
ventions are the best way to measure and to improve con-
tinuity and coordination of care.
According to the subjective and objective measures 
employed in this study, the majority of patients in this 
cohort experienced high continuity and continuation of 
care along the informational, managerial and relational 
dimension. According to questionnaire 2, more than 
every second patient reported a high continuity of care 
according to the scoring scheme also employed in other 
studies (total score of ≥ 75 points in more than half of the 
patients). No significant difference was detected between 
the groups of patients who were seen by more or less 
than one PO over time. While it is widely accepted that 
PREMs are the most appropriate methodology to capture 
continuity of care, some authors have argued that they 
may also capture patient satisfaction, happiness or cur-
rent state of health [21–23]. Yet also with respect to other 
objective measures such as length of follow-up, number 
of clinical departments involved, follow-up lead or MDT 
involvement, no significant difference in the number of 
patients with satisfactory subjective continuity and care 
scores could be detected. This finding may indeed be due 
to the small sample size of this study.
However, the good subjective scores are generally rein-
forced by the examined objective measures: Despite an 
academic university hospital setting, the median patient 
saw only two POs over a large number of RT courses 
Table 4 Follow-up characteristics
MDT = Multidisciplinary tumor board; RT = Radiation therapy; PO = Primary oncologist
a Includes dermatology, gynecology and nuclear medicine
Parameter Data (n = 33 patients)
Follow-up in years since first RT course, median (range) 6 (3–13)
No. of clinical departments involved, median (range) 3 (2–6)
Department with follow-up lead, n (%)
 Oncology 13 (39.4%)
 Radiation Oncology 12 (36.4%)
  Othera 8 (24.2%)
No. of POs in Radiation Oncology department, median (range) 2 (1–5)
No. of RT courses discussed in MDT, n (%) 119 (56.7%)
Table 5 Overview of different continuity of care measures
Dept = Department; MDT = Multidisciplinary tumor board; PREMs = Patient 
reported experience measures; PO = Primary oncologist




No. of follow-up years 0.478
 < 6 4 (36)
 ≥ 6 7 (64)
No. of clinical depts involved 0.512
 < 3 6 (55)
 ≥ 3 5 (45)
Dept with follow-up lead 0.362




At least once 7 (64)
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over a long period of time (median of 6 RT courses and 
2 POs per patient), indicating satisfactory relational and 
informational continuity of care. The fact that POs in our 
department have two organ subspecialties on average 
and that there are standard operating procedures placing 
great importance on recurring patients being managed 
by the same PO from initial consult to post-treatment 
follow-up may have contributed to this good result. This 
also seems to be reflected in the high scores of the ques-
tions regarding the relational aspect of continuity of care 
in questionnaire 1. The scores did not differ significantly 
between patients who had more or less than two POs. 
These results may be due to the fact that patients were 
followed-up for years at our department which is an inte-
gral part of CCCZ. In addition, in a radiation oncology 
department, besides the physicians, patients regularly 
and continuously engage with a large care provider team 
consisting of nursing staff and radiation therapy techni-
cians who are present during all treatments, thus also 
contributing to the relational aspect of continuity of care.
Regular MDT meetings and case discussions are an 
integral part of cancer care in modern comprehensive 
cancer centers [24]. While there is a great variety in 
quality, format and frequency of MDT discussions, it 
is widely acknowledged that they improve quality and 
the managerial dimension of the continuity and coor-
dination of care [25]. The evidence regarding the effect 
of MDT case discussions on outcomes is not yet con-
clusive, with some studies reporting improved clini-
cal outcome and overall survival, while others merely 
found an association with higher recruitment to clini-
cal trials [26, 27]. While the proportion of physicians 
regularly participating in MDTs as well as the number 
of patient cases regularly presented in MDTs is known 
to greatly vary, actual quantification of such figures is 
widely absent from the literature. In this cohort, only 
57% of RT courses were discussed in MDTs, which falls 
short of the 80–95% sometimes required for compre-
hensive cancer center accreditation. This may present 
an indication of a lack of coordination among oncologi-
cal disciplines, which again could have translated into 
a lower managerial and informational continuity of 
care. One reason for this rather low figure might be due 
to the fact almost 80% of RT courses administered in 
this patient cohort had a palliative intent with patients 
directly referred for symptom palliation. In these cases, 
an MDT discussion sometimes has to be traded off 
against a delayed treatment start. As a Cochrane review 
of fifty-one interventional studies on continuity of care 
concluded that it is difficult to assess the effectiveness 
of interventions and to actually pin down factors that 
may have contributed to a lower perceived continuity of 
care, one also needs to be cautious in this study to draw 
definitive conclusions when trying to correlated objec-
tive measures of coordination and subjective PREMs 
for the continuity of care [28].
Shortcomings of this study consist in its retrospec-
tive nature and the limited number of patients receiving 
MRRT. Given that treatment logs for the past decade 
were screened to identify patients having received MRRT, 
a larger assessment will only be possible when includ-
ing multiple centers. Additional drawbacks of this study 
may originate from patients` chronic cancer disease and 
recall biases as well as from a long follow-up time with 
some patients having received their first RT treatment 
years ago. While the questionnaire response rate of effec-
tively around 60% can be taken to be on the higher end of 
studies of this type, it also represents of risk of responses 
being upward-biased, as patients who have already died 
or declined to participate may have been those with 
unmet care needs and thus a lower perceived continuity 
of care. Though memory of treatment details may have 
been distant in some cases, the great majority of patients 
was in regular follow-up. Also, having completed at least 
five courses of RT and being able to extensively comment 
on this experience was a prerequisite of being able to par-
ticipate in this study in the first place.
Yet, the strength of this study was the systematical 
assessment of the continuity and coordination of care 
in a large radiation oncology department of a tertiary 
center, using a validated questionnaire from the litera-
ture focusing on all three aspects of the continuity of 
care. Also, we placed particular importance on the rela-
tional aspect of the continuity of care, which is of cen-
tral importance to cancer patients, by using an in-house 
developed questionnaire collecting patient-reported 
outcomes. Moreover, we hope to inspire other radiation 
oncology departments to conduct similar studies, so that 
pooled-data or multi-center analyses will be possible in 
the near future.
In conclusion, MRRT patients treated at our depart-
ment and followed-up at the CCCZ over the past decade 
experienced high continuity of care by available meas-
ures. Further efforts should be undertaken to improve 
the informational, managerial and relational aspects 
of the continuity and coordination of care, for exam-
ple, through increased PO continuity or the more regu-
lar use of MDTs in all patient cases, in order to provide 
even more patient-centered medical care and follow-up 
management.
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